Sollis Therapeutics
Columbus, US · Founded 2017 · Delaware corporation · 26 employees on LinkedIn · 3 known investors
Find your way into Sollis Therapeutics
Sign up to see every warm intro you have to Sollis Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sollis Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AD
Alex DiNelloNamed on SEC filing
Investors · 3
Deerfield Management CompanyreportedNew York
How we know: funding news · finsmes.com · Not right? Tell us
Also in the syndicate · 2
DeerfieldleadNeurotechnology Innovations Translator
Funding
SEC filings, press & company announcements$55M disclosed across 3 rounds · 2018–2021
- $50MraisedApr 2018 · 3 sources
Deerfield (lead), Deerfield Management, Neurotechnology Innovations Translator
Source ↗
▶$2.5MraisedMar 2021 · 2 investors · BiotechnologyRule 506(c)
▶$2.5MraisedMar 2021 · 2 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Alex DiNelloExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
▶$2.5MraisedAug 2020 · 3 investors · BiotechnologyRule 506(c)
▶$2.5MraisedAug 2020 · 3 investors · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Alex DiNelloExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- Proceeds to insiders
- $30K
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Sollis Therapeutics's investors?
- Sollis Therapeutics's investors include Deerfield Management Company.
- How much funding has Sollis Therapeutics raised?
- Sollis Therapeutics has disclosed $55M raised across 3 rounds.
- Where is Sollis Therapeutics headquartered?
- Sollis Therapeutics is headquartered in Columbus, US.
